[1]
Elnahry, A.G. and Elnahry, G.A. 2019. REVERSIBLE NEUROTHROPHIC KERATOPATHY ASSOCIATED WITH ROSUVASTATIN THERAPY: A CASE REPORT. Journal of Population Therapeutics and Clinical Pharmacology. 26, 2 (Aug. 2019), e38-e42. DOI:https://doi.org/10.15586/jptcp.v26i2.627.